Sign Out
Agranulocytosis/Neutropenia: FERRIPROX can cause agranulocytosis that can lead to serious infections and death. Neutropenia may precede the development of agranulocytosis (see Precautions).
Measure the absolute neutrophil count (ANC) before starting FERRIPROX and monitor the ANC weekly on therapy (see Precautions).
Interrupt FERRIPROX if infection develops and monitor the ANC more frequently (see Precautions).
Advise patients taking FERRIPROX to report immediately any symptoms indicative of infection (see Precautions).
Lanjutkan dengan Google